Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Associate Director, Client Services
Brisbane, California · Posted on Mar 21, 2025
Clinical Data Scientist
Remote · Posted on Mar 21, 2025
Development Scientist I
Brisbane, California · Posted on Mar 21, 2025
Director, Product Marketing
Brisbane, California · Posted on Mar 21, 2025
Director, Sales Operations & Analytics
Brisbane, California · Posted on Mar 21, 2025
Future Consideration
Brisbane, California · Posted on Mar 21, 2025
Manager, Commercial Program Management
Remote · Posted on Mar 21, 2025
Senior Computational Biologist I
Brisbane, California · Posted on Mar 21, 2025
Senior Software Engineer I
Remote · Posted on Mar 21, 2025
Senior Software Engineer II
Remote · Posted on Mar 21, 2025
Senior Systems Administrator
Brisbane, California · Posted on Mar 21, 2025
Staff Development Scientist
Brisbane, California · Posted on Mar 21, 2025
Explore similar companies to Freenome
ClarityCare AI
Streamlining health insurance prior authorization.
Silna
Make care your primary focus.
Junction
Modernizing healthcare infrastructure.
RadiantGraph
Intelligent personalization for healthcare.
New Lantern
Automation radiolog-related tasks with AI.
Teton
Empowering healthcare staff through AI.
Sesame
Half-priced, high-quality health care.
Osmind
Tech for breakthrough mental health research.
Thatch
Modern health benefits platform.